Answers are grounded in this paper and cite their sources.
In this study, Box–Behnken RSM combined with single-factor trials was adopted to optimise hot-water extraction of crude polysaccharides from Platycodon grandiflorum roots. The maximal crude polysaccharide yield of 34.98% was achieved at 96 °C, three extraction cycles, 3.4 h and liquid-solid ratio of 25 mL g−1. After sequential DEAE-52 and Sephadex LH-20 chromatographic purification, a homogeneous fraction PGP-I(a) (2722 Da) was acquired. Comprehensive structural analyses verified PGP-I(a) as a linear inulin-type fructan composed of β-(2→1)-D-fructofuranosyl backbones terminated by one α-D-glucopyranosyl unit (Fru:Glc molar ratio = 94.12:5.88), with compact spherical aggregates observed via SEM. In vitro tests demonstrated concentration-dependent inhibition against α-amylase (IC50 = 0.17 mg•mL−1) and α-glucosidase (IC50 = 0.58 mg•mL−1); meanwhile, PGP-I(a) also inhibited pancreatic lipase, showing dual hypoglycaemic and lipid-lowering activities. This research offers theoretical support for high-value exploitation of Platycodon grandiflorum and the development of natural glycolipid-regulating additives.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: